ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
x/twitter facebook linkedin bluesky youtube instagram iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Evolving Standards of Care

A Decade of Changes in Lung Cancer, with More to Come

Dr. Joan Schiller
on: October 01, 2020In: Evolving Standards of Care
A Decade of Changes in Lung Cancer, with More to Come

Using data from SEER databases, Howlader and colleagues recently reported that incidence-based mortality from NSCLC in men decreased from 6.3% annually (95% CI, 3.4 to 9.0) from 2013 through 2016, in contrast to the period […] Read more


Stage IIIA NSCLC: A Review of Recent and Ongoing Trials

Mariano Provencio
on: September 30, 2020In: Evolving Standards of Care
Stage IIIA NSCLC: A Review of Recent and Ongoing Trials

Trial data can help inform change to standard of care, but at what point do we say enough data is enough and move forward with combination therapy as the new standard of care? Read more

Building and Maintaining a Patient–Physician Relationship in the COVID-19 Era

Robert Ramierz, DO
on: September 30, 2020In: Evolving Standards of Care
Building and Maintaining a Patient–Physician Relationship in the COVID-19 Era

As oncologists, we recognize that the patient–physician relationship is of utmost importance in establishing the patient’s trust in the physician and in the physician’s ability to learn more about the patient’s needs and perform accurate assessments for […] Read more

Multidisciplinary Tumor Board: A Single Institution’s Perspective

Ari Rosenberg, MD
on: September 30, 2020In: Evolving Standards of Care
Multidisciplinary Tumor Board: A Single Institution’s Perspective

As 7:00 AM approaches, the ninth-floor conference room slowly fills as team members fi le in and find their seats. The senior radiation oncologist identifies his seat in the front row, carefully placing his stack […] Read more

Dr. Harpreet Singh Discusses the Conduct of FDA Clinical Trials During the COVID-19 Pandemic

Harpreet Singh, MD
on: September 29, 2020In: Evolving Standards of Care, Industry News & Regulatory Approvals
Dr. Harpreet Singh Discusses the Conduct of FDA Clinical Trials During the COVID-19 Pandemic

Harpreet Singh, MD, is director of Division of Oncology 2 at the U.S. Food and Drug Administration (FDA). In the following interview, she discusses the FDA’s response to the COVID-19 […] Read more

COVID-19 and Thoracic Malignancies

Hina Khan, MD
+more
on: September 29, 2020In: Evolving Standards of Care
COVID-19 and Thoracic Malignancies

Coronavirus disease-2019 (COVID-19) is a novel infectious disease, mainly affecting the respiratory tract, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). COVID-19 emerged in Wuhan, China, in December […] Read more

IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens Following Neoadjuvant Therapies

Sanja Dacic
+more
on: September 29, 2020In: Diagnostic Oncology, Evolving Standards of Care
IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens
            Following Neoadjuvant Therapies

Treatment guidelines recommend neoadjuvant or adjuvant therapies with surgery for patients with large primary tumors or clinical evidence of intrathoracic nodal spread.1,2 A recent joint IASLC–U.S. Food and Drug Administration […] Read more

Small Steps Forward in SCLC: Is a Giant Leap on the Horizon?

Carl M. Gay
on: September 06, 2020In: Evolving Standards of Care
Small Steps Forward in SCLC: Is a Giant Leap on the Horizon?

The absence of an OS benefit in more than 3 decades of clinical trials for extensive-stage SCLC (ES-SCLC) had become an all-too-familiar refrain among the introductions to numerous publications and […] Read more

Liquid biopsy for early lung cancer detection and cancer interception

Christian Rolfo, MD, PhD, MBA, Drhc
on: September 06, 2020In: Evolving Standards of Care
Liquid biopsy for early lung cancer detection and cancer interception

By Christian Rolfo, MD, PhD, MBA, Dr.hc. Over the past several years, three large randomized clinical trials demonstrated that low-dose computed tomography (LDCT) screening is a valuable method for lung […] Read more

Telehealth: Bridging the Digital Divide Is Still a Work In Progress

on: August 20, 2020In: Evolving Standards of Care
Telehealth: Bridging the Digital Divide Is Still a Work In Progress

By Sandip Pravin Patel, MD, and Martin Edelman, MD Posted: August 21, 2020 Dr. Sandip Pravin Patel Dr. Martin Edelman                     […] Read more

«‹16171819202122›»

SEARCH ILCN

Archives

PROVIDER RESOURCES

MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC

INDUSTRY SUPPORTED


COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events

INDUSTRY SUPPORTED

POPULAR ARTICLES

Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2024 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy